Pharmacodynamic effect of clopidogrel in patients undergoing transcatheter aortic valve implantation

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Tousek, Petr ^a   Kocka, Viktor ^a   Sulzenko, Jakub ^a   Bednar, Frantisek ^a   Linkova, Hana ^a   Widimsky, Petr ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; TICLOPIDINE; DRUG DERIVATIVE;

AGED; ARTICLE; BOLUS INJECTION; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DRUG INDUCED DISEASE; FEMALE; FOLLOW UP; HEART INFARCTION; HEART TAMPONADE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERICARDIOCENTESIS; PLATELET REACTIVITY; THROMBOCYTE FUNCTION; TRANSCATHETER AORTIC VALVE IMPLANTATION; ACUTE CORONARY SYNDROME; ANALOGS AND DERIVATIVES; AORTA VALVE; BLOOD VESSEL PROSTHESIS; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; THROMBOCYTE; THROMBOCYTE ACTIVATION; VERY ELDERLY;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; AORTIC VALVE; BLOOD PLATELETS; BLOOD VESSEL PROSTHESIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MYOCARDIAL INFARCTION; PLATELET ACTIVATION; TICLOPIDINE;

EID: 84881511262     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/386074     Document Type: Article

References (13)

1. Mehta S. R., Yusuf S., Peters R. J. G., Bertrand M. E., Lewis B. S., Natarajan M. K., Malmberg K., Rupprecht H.-J., Zhao F., Chrolavicius S., Copland I., Fox K. A. A., Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. The Lancet 2001 358 9281 527 533 2-s2.0-0035908781 10.1016/S0140-6736(01)05701-4 (Pubitemid 32772726)
2. Marcucci R., Gori A. M., Paniccia R., Giusti B., Valente S., Giglioli C., Buonamici P., Antoniucci D., Abbate R., Gensini G. F., Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay. A 12-month follow-up. Circulation 2009 119 2 237 242 2-s2.0-59849120163 10.1161/CIRCULATIONAHA.108.812636
3. Price M. J., Endemann S., Gollapudi R. R., Valencia R., Stinis C. T., Levisay J. P., Ernst A., Sawhney N. S., Schatz R. A., Teirstein P. S., Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. European Heart Journal 2008 29 8 992 1000 2-s2.0-44949173754 10.1093/eurheartj/ehn046 (Pubitemid 351844676)
4. Steinhubl S. R., Berger P. B., Mann J. T. III, Fry E. T. A., DeLago A., Wilmer C., Topol E. J., Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. The Journal of the American Medical Association 2002 288 19 2411 2420 2-s2.0-0037145863 10.1001/jama.288.19.2411 (Pubitemid 35340537)
5. Wallentin L., Becker R. C., Budaj A., Cannon C. P., Emanuelsson H., Held C., Horrow J., Husted S., James S., Katus H., Mahaffey K. W., Scirica B. M., Skene A., Steg P. G., Storey R. F., Harrington R. A., Ticagrelor versus clopidogrel in patients with acute coronary syndromes. The New England Journal of Medicine 2009 361 11 1045 1057 2-s2.0-70149101223 10.1056/NEJMoa0904327
6. Wiviott S. D., Braunwald E., McCabe C. H., Prasugrel versus clopidogrel in patients with acute coronary syndromes. The New England Journal of Medicine 2007 357 2001 2015 10.1056/NEJMoa0706482 (Pubitemid 350106708)
7. Rodés-Cabau J., Dauerman H. L., Cohen M. G., Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events. Journal of the American College of Cardiology 2013 10.1016/j.jacc.2013.03.029
8. Zahn R., Gerckens U., Grube E., Linke A., Sievert H., Eggebrecht H., Hambrecht R., Sack S., Hauptmann K. E., Richardt G., Figulla H.-R., Senges J., Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. European Heart Journal 2011 32 2 198 204 2-s2.0-78651506594 10.1093/eurheartj/ehq339
9. Gilard M., Eltchaninoff H., Iung B., Donzeau-Gouge P., Chevreul K., Fajadet J., Leprince P., Leguerrier A., Lievre M., Prat A., Teiger E., Lefevre T., Himbert D., Tchetche D., Carrié D., Albat B., Cribier A., Rioufol G., Sudre A., Blanchard D., Collet F., Dos Santos P., Meneveau N., Tirouvanziam A., Caussin C., Guyon P., Boschat J., Le Breton H., Collart F., Houel R., Delpine S., Souteyrand G., Favereau X., Ohlmann P., Doisy V., Grollier G., Gommeaux A., Claudel J.-P., Bourlon F., Bertrand B., Van Belle E., Laskar M., Registry of transcatheter aortic-valve implantation in high-risk patients. The New England Journal of Medicine 2012 366 18 1705 1715 2-s2.0-84860436228 10.1056/NEJMoa1114705
10. Rodés-Cabau J., Webb J. G., Cheung A., Ye J., Dumont E., Feindel C. M., Osten M., Natarajan M. K., Velianou J. L., Martucci G., DeVarennes B., Chisholm R., Peterson M. D., Lichtenstein S. V., Nietlispach F., Doyle D., DeLarochellière R., Teoh K., Chu V., Dancea A., Lachapelle K., Cheema A., Latter D., Horlick E., Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. Journal of the American College of Cardiology 2010 55 11 1080 1090 2-s2.0-77649212932 10.1016/j.jacc.2009.12.014
11. Piazza N., Grube E., Gerckens U., den Heijer P., Linke A., Luha O., Ramondo A., Ussia G., Wenaweser P., Windecker S., Laborde J.-C., de Jaegere P., Serruys P. W., Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008 4 2 242 249 2-s2.0-55849132881
12. Ussia G. P., Scarabelli M., Mulè M., Barbanti M., Sarkar K., Cammalleri V., Imm S., Aruta P., Pistritto A. M., Gulino S., Deste W., Capodanno D., Tamburino C., Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation. American Journal of Cardiology 2011 108 12 1772 1776 2-s2.0-82555172331 10.1016/j.amjcard.2011.07. 049
13. Lynch D. R., Dantzler D., Robbins M., Zhao D., Considerations in antithrombotic therapy among patiens undergoing transcatheter aortic valve implantation. Journal of Thrombosis and Thrombolysis 2013 35 4 476 482 10.1007/s11239-013-0886-z